These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 37071122)
1. Diagnostic performance of multiparametric magnetic resonance imaging in the differentiation of clear cell renal cell cancer. Aydoğan C; Cansu A; Aydoğan Z; Erdemi S; Teymur A; Bektaş O; Mungan S; Kazaz İO Abdom Radiol (NY); 2023 Jul; 48(7):2349-2360. PubMed ID: 37071122 [TBL] [Abstract][Full Text] [Related]
2. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon. Halefoglu AM; Ozagari AA Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of Angiomyolipoma With Minimal Fat from Clear Cell Renal Cell Carcinoma Using Non-contrast Multiparametric Magnetic Resonance Imaging. Jomoto W; Takaki H; Yamamoto S; Kanematsu A; Igeta M; Hirota S; Yamakado K In Vivo; 2022; 36(6):2790-2799. PubMed ID: 36309367 [TBL] [Abstract][Full Text] [Related]
4. MR characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: comparison with clear cell and papillary subtypes of renal cell carcinoma. Takahashi H; Vikram R; Jimenez RE; Bolan CW; Kawashima A; Karam JA; Takahashi N Abdom Radiol (NY); 2021 Nov; 46(11):5250-5259. PubMed ID: 34338814 [TBL] [Abstract][Full Text] [Related]
5. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types. Wang X; Kong W; Wang Y; Wang Y; Chen Y; Shi Z; Liu Y J BUON; 2021; 26(5):2053-2058. PubMed ID: 34761616 [TBL] [Abstract][Full Text] [Related]
6. Quantitative multiparametric MR analysis of small renal lesions: correlation with surgical pathology. Yano M; Fowler KJ; Srisuwan S; Salter A; Siegel CL Abdom Radiol (NY); 2018 Dec; 43(12):3390-3399. PubMed ID: 29691619 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis. Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458 [TBL] [Abstract][Full Text] [Related]
8. Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement. Paschall AK; Mirmomen SM; Symons R; Pourmorteza A; Gautam R; Sahai A; Dwyer AJ; Merino MJ; Metwalli AR; Linehan WM; Malayeri AA Abdom Radiol (NY); 2018 Sep; 43(9):2424-2430. PubMed ID: 29520425 [TBL] [Abstract][Full Text] [Related]
9. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma. Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273 [TBL] [Abstract][Full Text] [Related]
10. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography. Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876 [TBL] [Abstract][Full Text] [Related]
11. Comparison of cortico-medullary phase contrast-enhanced MDCT and T2-weighted MR imaging in the histological subtype differentiation of renal cell carcinoma: radiology-pathology correlation. Halefoglu AM; Ozagari AA Pol J Radiol; 2021; 86():e583-e593. PubMed ID: 34876939 [TBL] [Abstract][Full Text] [Related]
12. Small (< 4 cm) Renal Tumors With Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma. Park JJ; Kim CK AJR Am J Roentgenol; 2017 Jan; 208(1):124-130. PubMed ID: 27824487 [TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade. Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915 [TBL] [Abstract][Full Text] [Related]
14. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Differentiation of Minimal Fat Angiomyolipoma from Clear Cell Renal Cell Carcinoma. Li H; Li A; Zhu H; Hu Y; Li J; Xia L; Hu D; Kamel IR; Li Z Acad Radiol; 2019 May; 26(5):632-639. PubMed ID: 30087067 [TBL] [Abstract][Full Text] [Related]
15. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI. Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980 [TBL] [Abstract][Full Text] [Related]
17. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT. Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739 [TBL] [Abstract][Full Text] [Related]
18. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT. Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359 [TBL] [Abstract][Full Text] [Related]
19. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging. Steinberg RL; Rasmussen RG; Johnson BA; Ghandour R; De Leon AD; Xi Y; Yokoo T; Kim S; Kapur P; Cadeddu JA; Pedrosa I Eur Radiol; 2021 Jan; 31(1):314-324. PubMed ID: 32770377 [TBL] [Abstract][Full Text] [Related]
20. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI. Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]